BGF
Assembly Line
Forefront RF secures £16M to power next-gen connectivity solutions
Forefront RF Ltd, a fabless semiconductor company based in Cambridge, UK, announced the closure of its £16 million Series A funding round, backed by existing investors BGF and Foresight Group, alongside new VC partners, Octopus Ventures and Cambridge Innovation Capital. This infusion of capital supports Forefront RF’s mission to redefine how mobile devices manage complex RF environments, expanding possibilities for connected devices worldwide. With this investment, the company is set to transition from an early-stage startup to a mature player in RF technology, gearing up for the 2026 launch of its first-generation product, the FFM51010, to the fast growing cellular-enabled smartwatch market.
Forefront RF’s groundbreaking technology, rooted in pioneering research by founder Dr. Leo Laughlin, empowers mobile device manufacturers to overcome printed circuit board (PCB) size limitations while supporting more frequency bands with simplified, cost-effective designs. The company’s first solution is aimed cellular-enabled wearables, where every millimetre of PCB is critical and expanding frequency band capabilities is essential. By replacing bulky fixed-frequency filters and duplexers with a self-configuring tunable duplexer, Forefront RF enables devices to dynamically adjust to any required frequency, reducing overall component list and manufacturing complexity. This innovation not only saves valuable PCB space but also minimizes variants, reducing waste and enhancing supply chain efficiency—creating a win-win for manufacturers and their CSR goals.
FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production
FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery specialist Volta Energy Technologies, current investors (Oxford Science Enterprises and University of Oxford), Excellis Holding and angels.
With a growing market valued at $24bn, fluorochemical manufacturing relies on a centuries-old, carbon-intensive process centred around hydrogen fluoride (HF), a highly-toxic, hazardous and difficult-to-handle chemical. FluoRok has developed a safe and sustainable approach completely bypassing HF and providing environmentally friendly access to fluorochemicals while reducing process costs. FluoRok’s groundbreaking innovation has gained substantial traction, attracting numerous potential customers across core markets of Li-ion battery electrolyte salts and agrochemicals.
The funding will support team growth and expanded production facilities for the initial supply of fluorinating reagents and lithium hexafluorophosphate (LiPF6), a key component of lithium-ion batteries.